In recent years femtech has emerged as a promising field in Japan. Femtech focuses on leveraging technology to address the unique health challenges faced by women, including menstruation, infertility, and menopause. With the aim of providing better solutions and support for women’s healthcare and innovation, Femtech Community Japan has created a comprehensive map highlighting the key players in the industry. The following…
Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page. This Week’s Highlights Kasha adds $21M in Series B funding to scale its women’s health platform in Africa. Family First secures $11M in Series A funding for its caregiver…
The SKYLARK Study, conducted by The Feinstein Institutes for Medical Research at Northwell Health, has shown promising results in treating postpartum depression (PPD). Led by Dr. Kristina M. Deligiannidis, the trial evaluated the efficacy of an investigational oral neuroactive steroid, zuranolone (50mg). The findings suggest zuranolone could become the first oral, at-home therapy approved by the FDA for PPD. The study included…
Israeli medtech company InMode is strengthing its position in the women’s health market through the acquisition of Viveve Medical‘s intellectual property assets. Viveve Medical specializes in women’s wellness and more specifically the treatment of female stress urinary incontinence (SUI). With the acquisition, all of Viveve’s worldwide patents have been transferred and registered under InMode. Earlier this year in January 2023 Viveve Medical,…
Infertility, once shrouded in silence and stigma, has become a subject of open discussion and understanding thanks to a gradual shift in public perspectives over the past couple of years. World IVF Day on July 25th is an opportunity to explore how IVF has contributed to breaking taboos surrounding infertility and reshaped societal attitudes towards assisted reproductive technologies. So today in honor…
Wisdom Ventures, an unconventional venture capital firm with a unique focus on mindfulness, compassion, well-being, and human connection, has closed its inaugural Fund I, raising an $10M. Since its initial $5M closing last year, Wisdom Ventures has strategically invested in 15 start-ups supporting technologies aimed at enhancing mental health, workplace well-being, and fostering human connections. Among its notable investments are start-ups such…
Zain Memon, a tech executive, established Eureka Health to address the lack of support for his mother, who was diagnosed with the rare condition MSA (similar symptoms to Parkinson’s). The startup recently secured a $7M in seed round led by Khosla Ventures. Other participants include South Park Commons, Bling Capital, SciFi VC, Able Partners and Bow Capital participated as well as 23andMe…
Emagine Solutions Technology has been awarded $1M in research and development (R&D) funding from the U.S. National Science Foundation (NSF). The funding, part of the NSF’s Small Business Innovation Research (SBIR) program, will be used to further develop proprietary AI models and integrate systems with the largest Electronic Health Record (EHR) system in the nation. This effort aims to strengthen The Journey…
